Variant report
Variant | esv3462777 |
---|---|
Chromosome Location | chr3:159255058-159259656 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-432B6.3.1-9 | chr3:159259268-159259491 | uc_130_- |
2 | lnc-IQCJ-2 | chr3:159259268-159259491 | uc_130_+ |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546647761 | chr3:159255079-159255080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115550982 | chr3:159255093-159255094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111852049 | chr3:159255150-159255151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140854102 | chr3:159255159-159255160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575511502 | chr3:159255175-159255176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186135936 | chr3:159255184-159255185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144608072 | chr3:159255206-159255207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572837918 | chr3:159255274-159255275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115314901 | chr3:159255308-159255309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190954562 | chr3:159255389-159255390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575117015 | chr3:159255461-159255462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117558766 | chr3:159255471-159255472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61794727 | chr3:159255666-159255667 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs116526048 | chr3:159255690-159255691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552545788 | chr3:159255773-159255774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183409666 | chr3:159255780-159255781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530789357 | chr3:159255832-159255833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61794728 | chr3:159255857-159255858 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs187820695 | chr3:159255858-159255859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568193179 | chr3:159255879-159255880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535300899 | chr3:159255880-159255881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116630763 | chr3:159255912-159255913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190783460 | chr3:159255918-159255919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1387692 | chr3:159255920-159255921 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs182906751 | chr3:159255928-159255929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539730836 | chr3:159255956-159255957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547845602 | chr3:159255997-159255998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs5853868 | chr3:159256038-159256039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs398091932 | chr3:159256044-159256045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201673824 | chr3:159256046-159256047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561000657 | chr3:159256099-159256100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575913305 | chr3:159256101-159256102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117592911 | chr3:159256201-159256202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138410249 | chr3:159256224-159256225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533751512 | chr3:159256240-159256241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555538622 | chr3:159256248-159256249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187244912 | chr3:159256262-159256263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543941569 | chr3:159256276-159256277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369955732 | chr3:159256295-159256296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557532114 | chr3:159256298-159256299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149239986 | chr3:159256338-159256339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373416449 | chr3:159256426-159256427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546514625 | chr3:159256475-159256476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200798864 | chr3:159256476-159256477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528494473 | chr3:159256545-159256546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147311052 | chr3:159256586-159256587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140625712 | chr3:159256597-159256598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115769751 | chr3:159256636-159256637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561718829 | chr3:159256650-159256651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114135921 | chr3:159256679-159256680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:159253400-159256200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr3:159253600-159257000 | Enhancers | Liver | Liver |
3 | chr3:159255800-159256600 | Enhancers | Rectal Smooth Muscle | rectum |
4 | chr3:159258200-159259400 | Enhancers | Fetal Brain Male | brain |